Vice President Clinical Pharmacology
John A. Oates MD

With the experience of a number of drug discovery projects in my professional career,  have been working on a number of projects related to the mechanism of action of arachidonic acid peroxidation, such as sEH, and FLAP.  In addition to that, I have specific experience in the study of idiosyncratic toxicity using GSH adduct formation technique.

B. Positions and Honors
Positions and Employment

2000-2002 Post Doctoral fellow, The Ohio State University, Columbus, OH, 
2002-2008 Senior Scientist, Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT
2008-2012  Principal Scientist, Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT  
2012-2013  Associate Vice President of Research, KBP Biosciences Co., Ltd. Jinan, Shandong, China.
2013-Present    President and CEO, Synovel Laboratory Co., Ltd. Jinan, Shandong, China.
2014- Present Vice President, Chemistry VDDI Pharmaceuticals
2014-present  Member, Scientific Advisory Board and Consultant VDDI Pharmaceuticals


        

go back go next